U.S. Hospitality Stock News

If you are wondering whether Guardant Health at around US$90.36 is still fairly priced or starting to look stretched, the key question is what that tag says about the underlying business. The stock has seen sharp swings, with a 15.0% move over the last 7 days, 6.1% over 30 days, a 100.9% return over 1 year and a 268.7% return over 3 years, while the 5 year return sits at a 42.9% decline and the year to date return at an 11.2% decline. Recent headlines around Guardant Health have focused on...

Kaspi.kz has already held its 15 April 2026 Annual General Meeting, approving 2025 dividends of KZT 850 per common share, payable in cash from 15 April 2026 to shareholders of record on 14 April 2026. The AGM also confirmed Deloitte LLP as external auditor for 2026, reinforcing continuity in Kaspi.kz’s financial reporting and dividend distribution framework. We’ll now examine how this sizeable cash dividend decision fits into Kaspi.kz’s investment narrative around margins, capital...

Earlier this month, Oxford BioTherapeutics announced a multi-year collaboration with Bristol Myers Squibb to discover and develop novel T‑cell engager therapies for solid tumours, using OBT’s OGAP‑Verify platform to identify tumour‑selective targets while BMS leads later-stage development and commercialisation. The deal deepens Bristol Myers Squibb’s oncology partnerships by giving it access to next-generation T‑cell engager candidates sourced and designed externally, potentially enriching...

Why Citi’s downgrade has put Flutter Entertainment (NYSE:FLUT) under closer scrutiny Citi’s downgrade of Flutter Entertainment (NYSE:FLUT) to sell, tied to concerns about US growth, profit targets, and possible delays to buybacks, has pushed investors to reassess the stock’s risk profile. See our latest analysis for Flutter Entertainment. At a share price of $110.08, Flutter’s 7 day share price return of 7.52% and 1 day gain of 0.94% sit against a 90 day share price return decline of 41.59%...

If you are wondering whether GE HealthCare Technologies is attractively priced or starting to look stretched, the current setup offers plenty for valuation focused investors to unpack. The stock last closed at US$74.66, with returns of 2.0% over 7 days, 7.2% over 30 days, a 9.9% decline year to date, and a 20.0% gain over 1 year, which gives a mixed picture of recent performance. Recent coverage has centered on GE HealthCare Technologies as a standalone medical technology player following...

Event context and recent share performance Luckin Coffee (OTCPK:LKNC.Y) has drawn investor attention after recent trading, with the stock last closing at $33.79 and showing a 3.5% one day move, alongside mixed returns over the month and past 3 months. See our latest analysis for Luckin Coffee. While the latest 3.5% one-day share price return has caught attention, the year-to-date share price return of a 4.6% decline contrasts with a 10.6% one-year total shareholder return and a very large...

Wondering if Kinsale Capital Group at US$360.78 is a bargain, a premium, or somewhere in between? This article walks through the numbers so you can judge the current price with more confidence. The stock has returned 3.6% over the last 7 days and 9.9% over the last 30 days, yet it is still down 8.1% year to date and 25.6% over the past year, following a 108.1% return over 5 years. Recent share price moves have kept Kinsale Capital Group on many investors' watchlists, as they weigh up how the...

Recently, a critical article highlighted that Selective Insurance Group’s earnings per share and book value growth have trailed peers, raising questions about management’s capital allocation and return on equity compared with other insurers. This negative analyst commentary has drawn attention to the gap between Selective’s current performance metrics and those of its industry rivals, putting management’s execution under closer investor scrutiny. Now we’ll examine how concerns over lagging...

EPAM Systems, Inc. previously proposed amending its Fourth Amended and Restated Certificate of Incorporation to allow shareholders to call special meetings, alongside urging investors in its April 6, 2026 definitive proxy filing to vote against a separate shareholder proposal seeking a 10% ownership threshold for calling such meetings. This contrast between management’s preferred approach and an activist-backed, lower threshold highlights an evolving power balance over how quickly investors...

Wondering whether Onto Innovation at around US$290.76 is offering good value or stretched pricing? This article breaks down what the current market is implying about the stock. The share price context includes a 13.1% return over the last 7 days, 45.3% over 30 days, 75.3% year to date, 152.9% over 1 year, 251.5% over 3 years and 315.5% over 5 years. These moves sit against a backdrop where investors are paying closer attention to semiconductor suppliers tied to advanced manufacturing and...

For readers wondering whether Woodward's recent share price puts it at a bargain or a stretch, this article walks through the numbers so you can judge how the current price lines up with underlying value. The stock last closed at US$394.83, with returns of 1.6% over 7 days, 11.7% over 30 days, 27.0% year to date, 134.4% over 1 year, 327.0% over 3 years and 228.0% over 5 years. These moves have kept Woodward on many investors' radar, with recent coverage focusing on what might be driving such...

If you are wondering whether RTX is still reasonably priced after its recent run, it helps to step back and look at what the current share price might already be assuming. The stock closed at US$196.42, with returns of 4.9% year to date and 55.0% over the last year, following a 2.6% pullback in the past week and a 0.9% move over the last month. Recent headlines around RTX have focused on its position within the Aerospace and Defense sector and its role as a large US contractor. This keeps...

Earnings, buybacks and credit quality in focus FB Financial (FBK) just reported first quarter 2026 results, with higher net interest income and net income than a year ago, alongside an update on share repurchases and credit costs. See our latest analysis for FB Financial. The latest results, share repurchases and relatively contained credit costs come against a backdrop of a 6.05% 1 month share price return and a 34.99% 1 year total shareholder return. This suggests momentum has been uneven...

Moderna recently presented positive Phase 1/2 data for its investigational cancer antigen therapy mRNA-4359 in combination with pembrolizumab in advanced melanoma, and the U.S. FDA granted the regimen Fast Track designation for a specific PD-L1 positive melanoma population. The strong early response and disease control rates, together with regulatory acceleration, highlight how Moderna is extending its mRNA platform beyond infectious disease vaccines into oncology. We’ll now examine how the...

Executive reshuffle puts technology and brand expansion in focus E.l.f. Beauty (ELF) has shaken up its leadership team, promoting longtime chief marketing officer Kory Marchisotto to president of E.l.f. Brands, naming Oshiya Savur as chief marketing officer, and creating a chief technology and AI officer role for Ekta Chopra. The company is explicitly positioning technology and artificial intelligence as central to its growth plans, a development that could influence how you think about the...

If you are wondering whether Amgen’s share price still offers value after a strong run, this breakdown will help you weigh what you are really paying for. At a last close of US$355.30, the stock has returned 1.2% over 7 days, 2.2% over 30 days, 8.4% year to date, 32.2% over 1 year, 60.1% over 3 years, and 61.7% over 5 years. These figures raise fair questions about what is already reflected in the price. Recent attention around Amgen has focused on its role as a large US biotech, with...

Generac Holdings (GNRC) recently announced a collaboration with CPower Energy to deploy distributed generation across the PJM market, focusing on battery storage, generators and microgrids for commercial and industrial customers. See our latest analysis for Generac Holdings. The latest partnership news comes as Generac’s share price, now at $212.10, has seen a 6.42% 1 month share price return and a 31.86% 3 month share price return, with 1 year total shareholder return of 89.85% pointing to...

Earlier this month, Wells Fargo announced that Wyndham Rewards joined its Rewards Points Transfer program, allowing eligible Wells Fargo credit cardholders to convert points into Wyndham stays at a 1:2 ratio across thousands of properties worldwide. This move deepens Wyndham’s reach into bank-led loyalty ecosystems, potentially increasing customer engagement with its rewards program and enhancing the appeal of its largely midscale and economy hotel portfolio. We’ll now explore how the Wells...

Astronics (NasdaqGS:ATRO) has introduced its new EmPower Qi2 Wireless Charging Module for aircraft cabins, galleys, and crew rest areas. The module supports the latest Qi enabled and MagSafe compatible devices and is designed for rapid maintenance and compliance with aviation standards. Astronics focuses on aerospace and defense electronics, with cabin power and connectivity as a core part of its business. The EmPower Qi2 Wireless Charging Module fits directly into that franchise and aims...

Aktis Oncology (NasdaqGS: AKTS) has appointed Dr. Glenn Gormley as an independent director to its Board. Dr. Gormley will also serve as co-chair of a newly formed Science and Technology Committee. The company announced upcoming departures of two current Board members as part of this transition. Aktis Oncology, trading on NasdaqGS under the ticker AKTS, recently closed at $20.25. The stock is up 20.0% over the past week and 14.4% over the past 30 days, while the year-to-date return stands at...

Earlier in April 2026, Brinker International’s Chili’s brand introduced new Big Crispy and Spicy Big Crispy chicken sandwiches within its 3 For Me value combo, backed by upcoming television advertising and a New York City pop-up aimed directly at fast-food competitors. This move highlights Chili’s effort to fuse value-oriented bundles with more premium chicken sandwich options, seeking to protect margins while challenging quick-service chains for traffic. We’ll now examine how Chili’s...

Royal Caribbean Cruises (NYSE:RCL) has formally launched the Royal Caribbean Group Foundation, a dedicated philanthropy arm focused on ocean communities and health partnerships. The company has also been recognized as an industry leader in using artificial intelligence across its cruise operations and commercial functions. Royal Caribbean Cruises, trading on the NYSE under ticker RCL, is adding fresh context to its investment profile with these developments. The stock trades at $285.48 and...

If you are wondering whether Prologis at around its recent price of US$145.10 still offers value, it helps to step back and look at what the current valuation is actually pricing in. The stock has posted returns of 5.8% over the last 7 days, 13.4% over 30 days, 12.4% year to date and 47.1% over 1 year, which naturally raises questions about how much of the story is already reflected in the share price. Recent coverage has focused on Prologis as a large industrial REIT, with attention on how...

Recent coverage around MP Materials (MP) has zeroed in on its push into magnet production, its long-term supply agreements with the U.S. Department of Defense and Apple, and related commentary that appears to have refreshed investor interest. See our latest analysis for MP Materials. The 1 year total shareholder return of 131.46% and 3 year total shareholder return of 168.21% stand in sharp contrast to the 90 day share price return of an 11.58% decline. This suggests momentum has cooled...